“immune-system” Archives

in
Entry Author Date Location
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up 05/12/14 San Francisco
Myriad RBM Test Helping to Mine Secrets of Normal Immune System 04/16/14 Texas
Biotech DecImmune Grabs $1M from Astellas VC 09/27/10 Boston
Novartis Test Drives Biotech Startup Adimab’s Drug Discovery Engine 07/09/10 Boston
Technology Alliance Showcases Five Companies in Sensors, Mobile Displays, and Drug Therapies: Investors Take Notice 04/22/10 Seattle
Omeros Gets Ready for IPO, Cray Buys SiCortex Assets, ClearEdge Raises Cash, & More Seattle-Area Deals News 09/01/09 Seattle
GSK biotech subsidiary Tempero Pharma launched in the Boston area 05/15/09 Boston
Avila Therapeutics May Have Found “Achilles’ Heel” of Hepatitis C Virus 04/27/09 Boston
Page 1 of 1